353 related articles for article (PubMed ID: 20060370)
1. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.
Potapenko IO; Haakensen VD; Lüders T; Helland A; Bukholm I; Sørlie T; Kristensen VN; Lingjaerde OC; Børresen-Dale AL
Mol Oncol; 2010 Apr; 4(2):98-118. PubMed ID: 20060370
[TBL] [Abstract][Full Text] [Related]
2. Glycan-related gene expression signatures in breast cancer subtypes; relation to survival.
Potapenko IO; Lüders T; Russnes HG; Helland Å; Sørlie T; Kristensen VN; Nord S; Lingjærde OC; Børresen-Dale AL; Haakensen VD
Mol Oncol; 2015 Apr; 9(4):861-76. PubMed ID: 25655580
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation in breast cancer progression and mammary development: Molecular connections and malignant transformations.
Liang D; Gao Q; Meng Z; Li W; Song J; Xue K
Life Sci; 2023 Aug; 326():121781. PubMed ID: 37207809
[TBL] [Abstract][Full Text] [Related]
4. An Atlas of Human Glycosylation Pathways Enables Display of the Human Glycome by Gene Engineered Cells.
Narimatsu Y; Joshi HJ; Nason R; Van Coillie J; Karlsson R; Sun L; Ye Z; Chen YH; Schjoldager KT; Steentoft C; Furukawa S; Bensing BA; Sullam PM; Thompson AJ; Paulson JC; Büll C; Adema GJ; Mandel U; Hansen L; Bennett EP; Varki A; Vakhrushev SY; Yang Z; Clausen H
Mol Cell; 2019 Jul; 75(2):394-407.e5. PubMed ID: 31227230
[TBL] [Abstract][Full Text] [Related]
5. Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.
Haakensen VD; Steinfeld I; Saldova R; Shehni AA; Kifer I; Naume B; Rudd PM; Børresen-Dale AL; Yakhini Z
Mol Oncol; 2016 Jan; 10(1):59-72. PubMed ID: 26321095
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.
Kannagi R; Sakuma K; Miyazaki K; Lim KT; Yusa A; Yin J; Izawa M
Cancer Sci; 2010 Mar; 101(3):586-93. PubMed ID: 20085584
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
[TBL] [Abstract][Full Text] [Related]
9. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of glycosylation-associated genes in breast cancer.
Milde-Langosch K; Karn T; Schmidt M; zu Eulenburg C; Oliveira-Ferrer L; Wirtz RM; Schumacher U; Witzel I; Schütze D; Müller V
Breast Cancer Res Treat; 2014 Jun; 145(2):295-305. PubMed ID: 24737166
[TBL] [Abstract][Full Text] [Related]
11. I-branched carbohydrates as emerging effectors of malignant progression.
Dimitroff CJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):13729-13737. PubMed ID: 31213534
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells.
Montgomery MR; Hull EE
BMC Cancer; 2019 Jan; 19(1):79. PubMed ID: 30651077
[TBL] [Abstract][Full Text] [Related]
13. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
14. An integrated platform for mucin-type O-glycosylation network generation and visualization.
Le T; O'Brien C; Gupta U; Sousa G; Daoutidis P; Hu WS
Biotechnol Bioeng; 2019 Jun; 116(6):1341-1354. PubMed ID: 30739313
[TBL] [Abstract][Full Text] [Related]
15. "Casting" light on the role of glycosylation during embryonic development: insights from zebrafish.
Flanagan-Steet HR; Steet R
Glycoconj J; 2013 Jan; 30(1):33-40. PubMed ID: 22638861
[TBL] [Abstract][Full Text] [Related]
16. Monitoring glycosylation metabolism in brain and breast cancer by Raman imaging.
Kopec M; Imiela A; Abramczyk H
Sci Rep; 2019 Jan; 9(1):166. PubMed ID: 30655566
[TBL] [Abstract][Full Text] [Related]
17. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
18. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.
Guo H; Abbott KL
Adv Cancer Res; 2015; 126():281-303. PubMed ID: 25727151
[TBL] [Abstract][Full Text] [Related]
19. Glycogene expression profiles from a HaCaT cell line stably transfected with HPV16 E5 oncogene.
Cisneros-Ramírez D; Martínez-Laguna Y; Martínez-Morales P; Aguilar-Lemarroy A; Jave-Suárez LF; Santos-López G; Reyes-Leyva J; Vallejo-Ruiz V
Mol Med Rep; 2020 Dec; 22(6):5444-5453. PubMed ID: 33174037
[TBL] [Abstract][Full Text] [Related]
20. Role of protein glycosylation in cancer metastasis.
Oliveira-Ferrer L; Legler K; Milde-Langosch K
Semin Cancer Biol; 2017 Jun; 44():141-152. PubMed ID: 28315783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
